Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery-Reference-Cited by-同舟云学术

Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery

Published:2018-10-03 Issue:1 Volume:18 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Yuan Xianwen,Chen Jun,Cheng Qi,Zhao Yinjuan,Zhang Pengzi,Shao Xiaoyan,Bi Yan,Shi Xiaolei,Ding Yitao,Sun Xitai,Xue Bin

Funder

the National Natural Science Foundation of China

the Nature Science Foundation of Jiangsu Province

the Fundamental Research Funds for the Central Universities

the Open Fund of State Key Laboratory of Natural Medicines

Research of Institute of hospital management Nanjing University

the Innovation Capability Development Project of Jiangsu Province

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12876-018-0871-2.pdf

Reference29 articles.

1. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332:1519–23.

2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.

3. Lau JK, Zhang X, Yu J. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. J Pathol. 2017;241:36–44.

4. Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:1712–23.

5. Issa D, Alkhouri N. Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural history. Hepatobiliary Surg Nutr. 2017;6:401–3.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mutual regulatory loop between transcription factor Yin Yang 1 and hepatitis B virus replication influences chronic hepatitis B;Antiviral Research;2024-06

2. Exploring shared molecular signatures and regulatory mechanisms in nonalcoholic steatohepatitis and inflammatory bowel disease using integrative bioinformatics analysis;Scientific Reports;2024-05-27

3. Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation;Phytomedicine;2023-05

4. Correction to: YY1 inactivated transcription co‐regulator PGC‐1α to promote mitochondrial dysfunction of early diabetic nephropathy‐associated tubulointerstitial fibrosis;Cell Biology and Toxicology;2023-04-28

5. Dissecting the roles and clinical potential of YY1 in the tumor microenvironment;Frontiers in Oncology;2023-04-04